Binding to the promoters of STAT1 and PD-L1 genes, downregulating the expression of inflammatory factors and PD-L1, inhibiting the chronic inflammatory response-mediated tumorigenesis and tumor cell immune escape. The gene discussed is STAT1; the disease is neoplasm.